Hall R, Hyde J E, Goman M, Simmons D L, Hope I A, Mackay M, Scaife J, Merkli B, Richle R, Stocker J
Nature. 1984;311(5984):379-82. doi: 10.1038/311379a0.
The late blood stages of the human malaria parasite, Plasmodium falciparum, carry a major surface antigen, p190, of molecular weight (Mr) 190,000. This antigenically variable protein is actively processed, first as the parasite matures and again when it is released into the blood stream and invades a new erythrocyte to initiate a cycle of growth. It elicits a strong immune response in man; all tested adult sera from endemic areas have antibodies against this protein. Our evidence indicates that purified p190 can alter the course of parasitaemia in monkeys with falciparum malaria. We have also succeeded in cloning part of the gene for p190 and expressing it in Escherichia coli. To this end we have developed a new technique, antibody select, which greatly simplifies final identification of expressing clones.
人类疟原虫恶性疟原虫的晚期血液阶段携带一种主要表面抗原,即分子量(Mr)为190,000的p190。这种抗原性可变的蛋白质会被积极加工,首先是在寄生虫成熟时,然后是当它释放到血流中并侵入新的红细胞以启动生长周期时。它在人体内引发强烈的免疫反应;来自流行地区的所有检测过的成人血清都含有针对这种蛋白质的抗体。我们的证据表明,纯化的p190可以改变患恶性疟疾的猴子体内的寄生虫血症进程。我们还成功克隆了p190基因的一部分,并在大肠杆菌中进行了表达。为此,我们开发了一种新技术——抗体筛选,它极大地简化了对表达克隆的最终鉴定。